Central Dermatology

Saint Louis, Missouri 63117

Use our guide to learn which trials are right for you!

We've found
8 trials
at this facility
Dermatology / Plastic Surgery, Rheumatology Clinical Trial
Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Psoriasis Clinical Trial
Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hidradenitis Suppurativa Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Saint Louis, MO
Click here to add this to my saved trials